The biggest problem in the treatment of advanced pancreatic cancer is the acquired resistance against Gemcitabine [61] and NF-κB was shown to induce chemoresistance to gemcitabine in multiple ways. The gene discussed is NFKB1; the disease is familial pancreatic carcinoma.